🔎 Trials Near Me

Nyumbani › Limfoma ya Selu Kubwa za B Diffuse › Tennessee › Nashville

Majaribio ya kliniki ya Limfoma ya Selu Kubwa za B Diffuse katika Nashville, TN

Masomo 15 ya Limfoma ya Selu Kubwa za B Diffuse yanatafuta washiriki katika vituo vya Nashville na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.

Maandishi rasmi ya utafiti (Kiingereza)

Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL

InaajiriHatua 2
  • Vanderbilt University Medical Center, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06500273

Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma

InaajiriHatua 2
  • Vanderbilt University/Ingram Cancer Center, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07763210

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

InaajiriHatua 1/2
  • Tennessee Oncology, Pllc Nashville, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT05006716

A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)

InaajiriHatua 1/2
  • SCRI Oncology Partners ( Site 0100), Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Sep 2026 · NCT07519772

A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

InaajiriHatua 1
  • Sarah Cannon Research Institute, Nashville
  • Vanderbilt University Medical Center, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07226843

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

InaajiriHatua 1
  • SCRI Oncology Partners, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07101328

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

InaajiriHatua 1
  • Scri Oncology Partners, Nashville
  • Vanderbilt Medical Center, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT07195916

Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL

InaajiriHatua 2
  • Tennessee Oncology, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Sep 2026 · NCT06806033

Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies

InaajiriHatua 1/2
  • Sarah Cannon Research Institute, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT07284433

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

InaajiriHatua 1/2
  • Vanderbilt University Medical Center, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT05826535

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

InaajiriHatua 1/2
  • TriStar BMT, Nashville
Umri 13 hadi 90 · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

InaajiriHatua 3
  • SCRI Oncology Partners, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 4 Ago 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

InaajiriHatua 2
  • SCRI Oncology Partners, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT04792489

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

InaajiriHatua 1
  • Tennessee Oncology, Nashville
Umri 18 na zaidi · Jinsia zote · Imesasishwa 20 Mac 2026 · NCT04830137

Majaribio ya Limfoma ya Selu Kubwa za B Diffuse katika miji mingine

Masomo mengine katika Nashville

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.